Concordia Provides Update on Long-Term Growth Strategy

Pharmaceutical Investing

Concordia International shared an update on the company’s long-term plans.

Concordia International (NASDAQ:CXRX; TSX:CXR) shared an update on the company’s long-term plans.
As quoted in the press release:

Further to previous communications, the Company’s development of a long-term growth strategy is nearing completion. Once finalized, the Company intends to communicate its details with stakeholders in the second half of 2017.
To support the development and execution of this strategy, the Company has engaged Perella Weinberg Partners LP to provide financial advisory services. These services may include, but are not limited to, helping the Company explore and evaluate potential transactional alternatives, including initiatives to optimize its capital structure.
There can be no assurance that this process will result in any transaction, or that any transaction, if pursued, will be consummated. The Company does not expect to comment further unless and until a specific transaction is approved by its Board of Directors or the Company otherwise decides further disclosure is appropriate or required.
“We have made significant progress on our long-term growth strategy and we are looking forward to working with Perella Weinberg Partners to support the Company in finalizing and executing on that strategy,” said Allan Oberman, Chief Executive Officer of Concordia International Corp.

Click here to read the full press release.

Source: www.newswire.ca

The Conversation (0)
×